Scotté Florian, Hervé Christian, Leroy Pauline, Tourani Jean-Marc, Bensadoun René-Jean, Bugat Marie-Eve, Farsi Fadila, Jovenin Nicolas, Namer Moïse, Tournigand Christophe, Morin Sophie, Brami Cloé, Oudard Stéphane, Saadi Alexandre, Krakowski Ivan
Department of Oncology, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, 75105, Paris, France.
(AFSOS) Association Francophone pour les Soins Oncologiques de Support- French Speaking Association for Supportive Care in Cancer, Paris, France.
Support Care Cancer. 2017 Jul;25(7):2111-2118. doi: 10.1007/s00520-017-3615-x. Epub 2017 Feb 20.
Medical doctors' (MDs), but not patients', perception of supportive care in cancer (SCC) in France has been previously assessed in a national survey. This study evaluated MDs and patients' perceptions of the SCC organization and implementation in France.
The French SCC Association conducted two observational studies: study 1 (S1), containing a 30-point questionnaire sent to 2263 MDs, and study 2 (S2), containing a 40-point questionnaire sent to 2000 patients.
Overall, 711 MDs completed S1 and 1562 patients completed S2. In S1, 81% of MDs reported relying on a SCC organization and 76% attended SCC multidisciplinary discussions. MDs considered palliative (98%), psychological (98%), and social care (98%) as the top 3 SCC areas of importance for patients. In contrast, patients' priorities were psychology (61%), nutrition (55%) and organization of intake consultations (55%). The concept of SCC was familiar to 34% of patients; according to MDs, this concept was introduced mainly by MDs (78%) and admission nurses (41%). Outpatients identified as professional resources for SCC information general practitioners (84%), nurses (58%), and pharmacists (52%). Patients reported supportive treatment being prescribed in 63% of cases, with 64% receiving information on the negative side-effects. Among MDs, 87% reported proposing palliative and 41% adjuvant SCC treatment. Furthermore, 72% of MDs recommended SCC treatment at the metastatic stage, and 36% immediately following diagnosis.
Oncologists play a vital role in enhancing SCC efficacy. This can be increased by implementing a multidisciplinary integrated approach or by assuring the availability of patient information.
此前在一项全国性调查中评估了法国医生而非患者对癌症支持性护理(SCC)的认知。本研究评估了法国医生和患者对SCC组织与实施情况的认知。
法国SCC协会开展了两项观察性研究:研究1(S1),向2263名医生发送了一份包含30个问题的问卷;研究2(S2),向2000名患者发送了一份包含40个问题的问卷。
总体而言,711名医生完成了S1,1562名患者完成了S2。在S1中,81%的医生报告依赖SCC组织,76%的医生参加了SCC多学科讨论。医生认为姑息治疗(98%)、心理护理(98%)和社会护理(98%)是对患者最重要的前3个SCC领域。相比之下,患者的首要需求是心理护理(61%)、营养(55%)和会诊安排(55%)。34%的患者熟悉SCC概念;据医生称,这一概念主要由医生(78%)和入院护士(41%)引入。门诊患者将全科医生(84%)、护士(58%)和药剂师(52%)视为SCC信息的专业来源。患者报告63%的病例中开具了支持性治疗,64%的患者收到了关于负面副作用的信息。在医生中,87%的医生报告建议进行姑息性SCC治疗,41%的医生建议进行辅助性SCC治疗。此外,72%的医生建议在转移阶段进行SCC治疗,36%的医生建议在确诊后立即进行。
肿瘤学家在提高SCC疗效方面发挥着至关重要的作用。可以通过实施多学科综合方法或确保患者信息的可获取性来提高疗效。